Conagra Brands reported first-quarter 2026 results with net sales of US$2.63 billion and net income of US$164.5 million, both lower than a year earlier, but surpassed analyst forecasts and reaffirmed its full-year financial outlook despite inflation and tariffs.

An interesting detail is that management emphasized ongoing cost-saving measures and stable dividend payments, while also confirming the completion of a long-running share repurchase program.

Next, we'll explore how Conagra’s stronger-than-expected quarterly results and guidance reaffirmation influence its previously outlined investment narrative.

AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

To be a shareholder in Conagra Brands today, you need to have confidence in its ability to manage volatility in input costs and shifting consumer preferences, especially during inflation and tariff pressures. The latest quarterly results, which beat expectations but showed lower sales and earnings year over year, provide some reassurance but do not materially change the primary short-term catalyst: Conagra’s success in using cost-saving initiatives to offset higher costs. The biggest immediate risk remains persistent inflation and further tariff impacts pressuring margins.

Among recent announcements, the reaffirmation of Conagra’s full-year financial guidance stands out. Despite ongoing headwinds, management’s commitment to continuing with its existing financial targets signals confidence in their mitigation strategies and cost-control measures, directly tying into near-term catalysts for the stock. This steady outlook matters most for investors weighing whether operational discipline can counterbalance a tough pricing and supply environment.

Yet, in contrast, investors should also be aware that persistent supply chain and cost inflation could still...

Read the full narrative on Conagra Brands (it's free!)

Conagra Brands' narrative projects $11.4 billion revenue and $905.9 million earnings by 2028. This requires a 0.5% annual revenue decline and a $294.1 million decrease in earnings from the current $1.2 billion.

Uncover how Conagra Brands' forecasts yield a $20.58 fair value, a 7% upside to its current price.

The Simply Wall St Community’s 11 fair value estimates for Conagra Brands range widely from US$13.84 to US$48.23 per share. With inflation and tariffs remaining a significant risk to margins, these varied outlooks remind you to explore several viewpoints and consider all angles before making decisions.

Explore 11 other fair value estimates on Conagra Brands - why the stock might be worth over 2x more than the current price!

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

A great starting point for your Conagra Brands research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Our free Conagra Brands research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Conagra Brands' overall financial health at a glance.

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

Find companies with promising cash flow potential yet trading below their fair value.

Uncover the next big thing with financially sound penny stocks that balance risk and reward.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CAG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com